Cosmetics testing ban after 2026

Summary#

Wisconsin SB 1182 would have created a new section of state law; it does not amend an existing Act. Its goal was to restrict animal testing for cosmetics and cosmetic ingredients, and to limit the sale and import of products developed using certain tests. The bill failed, so it did not change the law.

  • After December 31, 2026, a cosmetic manufacturer could not conduct or contract for cosmetic animal testing in Wisconsin.
  • A manufacturer could not manufacture or import for profit into Wisconsin a cosmetic or ingredient if it knew or reasonably should have known it was developed or manufactured using cosmetic animal testing conducted after that date.
  • Starting July 1, 2027, a manufacturer could not sell or offer such a cosmetic for sale in Wisconsin under the same knowledge standard.
  • The bill defined cosmetic animal testing as applying a cosmetic or cosmetic ingredient internally or externally to a live, nonhuman vertebrate. It excluded merely reviewing, assessing, or keeping test evidence from the meaning of developing or manufacturing using such testing.
  • The prohibitions had exceptions for specified regulatory testing and for cosmetics or ingredients subject to certain federal food and drug law provisions.

What it means for you#

  • Cosmetic manufacturers: The bill would have restricted testing they conduct or arrange in Wisconsin, and certain manufacturing, importing, and sales tied to post-2026 animal tests. “Cosmetic manufacturer” means a person whose name appears on the product label as required by federal rules.
  • Researchers and testing contractors: The bill would have restricted cosmetic manufacturers from conducting or contracting for covered tests in Wisconsin after December 31, 2026. It would not have banned all animal testing, including testing for purposes unrelated to cosmetics.
  • Consumers: The bill would not have directly changed consumer rights or created a consumer benefit. It could have limited the sale of some cosmetics, subject to the exceptions.
  • General public: Because the bill failed, these restrictions and penalties did not take effect.

Money#

No publicly available information on the bill’s estimated implementation costs.

  • A person who violated the proposed law would have faced a $5,000 forfeiture (monetary penalty) for the violation, plus $1,000 for each day it continued after the first day.
  • The bill did not state a public spending amount, staffing requirement, or cost for enforcement. The proposed penalties were not enacted.

What is unclear#

  • The bill did not identify who would investigate or enforce violations, or how a violation would be established.
  • It did not set out a process for deciding what a manufacturer knew or reasonably should have known.
  • It incorporated a federal definition of “cosmetic ingredient” by reference; that definition is not included in the supplied text.
  • The regulatory exceptions depend on detailed conditions. The bill did not explain how compliance with those conditions would be checked.
  • The bill did not describe how these restrictions would interact with other state or federal programs beyond the listed exceptions.

Case for#

  • The bill appears intended to reduce cosmetic animal testing by restricting both testing in Wisconsin and some sales or imports linked to later testing.
  • Applying the restrictions to products made or sold using covered tests could address testing arranged outside Wisconsin as well as testing conducted in the state.
  • The exceptions would have allowed specified testing required by regulators when stated conditions were met, rather than making the restrictions absolute.
  • The bill would not have treated simply reviewing or retaining test evidence as using animal testing to develop or manufacture a product.

Case against#

  • One concern is that the “knows or reasonably should know” standard could be difficult for manufacturers to apply when they rely on information from others.
  • The exceptions are detailed and depend on judgments about ingredient use, health risks, accepted testing methods, and whether evidence was relied on.
  • The bill did not specify an enforcement process or how agencies would determine whether an exception applied.
  • The penalties could accumulate by the day, but the bill did not provide an estimate of how often violations might occur or what enforcement would cost.